Lenacapavir has been registered by SAHPRA as an innovative HIV prevention injection. Find out more about its rollout in South Africa.
Lenacapavir Approved for HIV Prevention in South Africa
Original Article by Marcus Louw | Spotlight | 28 October 2025
Lenacapavir has been registered by SAHPRA as an innovative HIV prevention injection. Find out more about its rollout in South Africa.
More Posts
Dis-Chem succession enters a new phase
The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.
Read more...
Ectopic pregnancy deaths expose care gaps
Ectopic pregnancy deaths remain preventable in South Africa as delayed diagnosis and treatment expose gaps in district care.
Read more...
Childhood immunisation coverage falls sharply in SA
Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.
Read more...